Cargando…
Exogenous surfactant application in a rat lung ischemia reperfusion injury model: effects on edema formation and alveolar type II cells
BACKGROUND: Prophylactic exogenous surfactant therapy is a promising way to attenuate the ischemia and reperfusion (I/R) injury associated with lung transplantation and thereby to decrease the clinical occurrence of acute lung injury and acute respiratory distress syndrome. However, there is little...
Autores principales: | Dreyer, Niels, Mühlfeld, Christian, Fehrenbach, Antonia, Pech, Thomas, von Berg, Sebastian, Nagib, Ragi, Richter, Joachim, Wittwer, Thorsten, Wahlers, Thorsten, Ochs, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265285/ https://www.ncbi.nlm.nih.gov/pubmed/18205928 http://dx.doi.org/10.1186/1465-9921-9-5 |
Ejemplares similares
-
Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A
por: Fehrenbach, Heinz, et al.
Publicado: (2005) -
Ultrastructural changes of the intracellular surfactant pool in a rat model of lung transplantation-related events
por: Knudsen, Lars, et al.
Publicado: (2011) -
Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation
por: Wittwer, Thorsten, et al.
Publicado: (2014) -
On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
por: Ochs, Matthias, et al.
Publicado: (2020) -
Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran
por: Ochs, Matthias, et al.
Publicado: (2006)